Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Ranbaxy buy in line with Sun's strategy
Sun Pharma’s recent purchase of ailing Ranbaxy Laboratories might have come as a surprise but analysts said the deal was in sync with the character of Mumbai-headquartered drug maker, known......
Sun Pharma keen to enter Japan's generics market
Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of......
New techs to drive patent filings in India
Patent filings in India would be more and more driven by new technologies, which are either kept secret or patented. In line with this, there will be a big shift towards protection of......
Sun Pharma in talks to buy Meda for $5-$6 billion
Sun Pharmaceutical Industries Ltd is in talks to buy Swedish drugmaker MedaAB for $5 billion-$6 billion to boost its generics business in developed markets, two sources with direct knowledge of the......
Markets remain firm, Tata Motors top gainer
Benchmark Indices are trading on a higher note led by Auto, Metal and Oil & Gas shares.Meanwhile, building confidence that the US will reach a budget deal with Congress to avoid fiscal cliff has......
bharatiya janata party
united progressive alliance
national democratic alliance
rashtriya swayamsevak sangh
central bureau of investigation
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2022 Rediff.com